Trevena (Trevena) 5-Year EBITDA Growth Rate : 13.70% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Trevena 5-Year EBITDA Growth Rate?

Trevena's EBITDA per Share for the three months ended in Dec. 2023 was $-0.92.

During the past 3 years, the average EBITDA Per Share Growth Rate was 20.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.70% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 22.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Trevena was 49.00% per year. The lowest was -30.30% per year. And the median was 11.05% per year.

Competitive Comparison of Trevena's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Trevena's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trevena's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Trevena's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Trevena's 5-Year EBITDA Growth Rate falls into.

Trevena 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Trevena (NAS:TRVN) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Trevena 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Trevena's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Trevena (Trevena) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Trevena Inc (NAS:TRVN) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

6T40:Germany

Address

955 Chesterbrook Boulevard, Suite 110, Chesterbrook, PA, USA, 19087

Website

https://www.trevena.com

Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Executives

Mark Corrigan	director
Mark Demitrack	officer: SVP, Chief Medical Officer	955 CHESTERBROOK BOULEVARD, SUITE 200, CHESTERBROOK PA 19087
Robert T Yoder	officer: SVP, Chief Business Officer	955 CHESTERBROOK BOULEVARD, SUITE 110, SUITE 200, CHESTERBROOK PA 19087
Carrie L. Bourdow	director, officer: President & CEO	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Patricia M. Drake	officer: SVP, Chief Commercial Officer	245 FIRST STREET, SUITE 1800, CAMBRIDGE MA 02142
Barry Shin	officer: SVP, CFO	C/O TREVENA, INC., 955 CHESTERBROOK BLVD, SUITE 110, CHESTERBROOK PA 19087
Marvin Johnson	director	C/O TREVENA, INC., 955 CHESTERBROOK BOULEVARD, STE. 110, CHESTERBROOK PA 19087
Barbara Yanni	director	1018 W. 8TH AVENUE, SUITE A, KING OF PRUSSIA PA 19406
Moulder Leon O Jr	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jason Raleigh Nunn	director	1119 ST. PAUL STREET, BALTIMORE MD 21202
Scott Braunstein	director	C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR MI 48108
Michael R Dougherty	director	C/O ADOLOR CORP, 700 PENNSYLVANIA DR, EXTON PA 19341
Anne M. Phillips	director	C/O TREVENA, INC., 1018 WEST 8TH AVENUE, KING OF PRUSSIA PA 19406
Scott Applebaum	officer: CLCO; SVP, Regulatory Affairs	C/O TREVENA INC., 955 CHESTERBROOK BOULEVARD, SUITE 110, CHESTERBROOK PA 19087
John P. Hamill	officer: Int. Prin. Fin. Off. and PAO	4092 NEW HOPE ROAD, FURLONG PA 18925